[1] 王拥军,李子孝,谷鸿秋,等. 中国卒中报告2019(中文版)(1)[J]. 中国卒中杂志,2020,15(10):1037-1043. Wang YJ,Li ZX,Gu HQ,et al.China stroke statistics 2019(1)[J]. Chin J Stroke,2020,15(10):1037-1043. [2] Johnston KC,Bruno A,Pauls Q,et al.Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke:the SHINE randomized clinical trial[J]. JAMA,2019,322(4):326-335. [3] Cui QY,Naikoo NA.Modifiable and non-modifiable risk factors in ischemic stroke:a meta-analysis[J]. Afr Health Sci,2019,19(2):2121-2129. [4] Pan YS,Chen WQ,Wang YJ.Prediabetes and outcome of ischemic stroke or transient ischemic attack:a systematic review and meta-analysis[J]. J Stroke Cerebrovasc Dis,2019,28(3):683-692. [5] Desilles JP,Meseguer E,Labreuche J,et al.Diabetes mellitus,admission glucose,and outcomes after stroke thrombolysis:a registry and systematic review[J]. Stroke,2013,44(7):1915-1923. [6] 冯翠玲,闫俊强,白树风. 进展性缺血性脑卒中与糖代谢异常的关系[J]. 医学综述,2016,22(5):925-928. Feng CL,Yan JQ,Bai SF.Study progress about the relation between progressive ischemic stroke and abnormal glucose regulation[J]. Med Recapitul,2016,22(5):925-928. [7] 卢舒颖,刘宁,廉民学. 糖尿病患者急性卒中后血糖监测及管理的最佳证据总结[J]. 护理学报,2021,28(15):42-47. Lu SY,Liu N,Lian MX.Best evidence summary of blood glucose monitoring and management in diabetes patients with acute stroke[J]. J Nurs China,2021,28(15):42-47. [8] 朱政,胡雁,邢唯杰,等. 不同类型循证问题的构成[J]. 护士进修杂志,2017,32(21):1991-1994. Zhu Z,Hu Y,Xing WJ,et al.The composition of different types of evidence based problems[J]. J Nurs Train,2017,32(21):1991-1994. [9] Brouwers MC,Kho ME,Browman GP,et al.AGREE II:advancing guideline development,reporting and evaluation in health care[J]. J Clin Epidemiol,2010,63(12):1308-1311. [10] 胡雁,郝玉芳. 循证护理学[M]. 卫生出版社,2018. Hu Y,Hao YF.Evidence-based nursing[M]. People's Medical Publishing House,2018. [11] Shea BJ,Reeves BC,Wells G,et al.AMSTAR 2:a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions,or both[J]. BMJ,2017,358:j4008. [12] 王春青,胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J]. 护士进修杂志,2015,30(11):964-967. Wang CQ,Hu Y.JBI evidence pre-classification and evidence rank system(2014 Edition)[J]. J Nurs Train,2015,30(11):964-967. [13] 国家卫生计生委脑卒中防治工程委员会. 中国脑卒中血糖管理指导规范(2015年版)[J]. 全科医学临床与教育,2016,14(1):3-5. Stroke Prevention and Control Engineering Committee,National Health and Family Planning Commission. Chinese guidelines for blood glucose management in stroke(2015 edition)[J]. Clin Educ Gen Pract,2016,14(1):3-5. [14] 北京高血压防治协会,北京糖尿病防治协会,北京慢性病防治与健康教育研究会,等. 基层心血管病综合管理实践指南2020[J]. 中国医学前沿杂志(电子版),2020,12(8):1-73. Beijing Hypertension Association,Beijing Diabetes Prevention and Treatment Association, Beijing Research for Chronic Diseases Control and Health Education,et al. Practise guideline(2020) for integrated management of cardiovascular diseases in primary hospitals[J]. Chin J Front Med Sci Electron Version,2020,12(8):1-73. [15] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志,2018,51(9):666-682. Chinese Society of Neurology,Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018[J]. Chin J Neurol,2018,51(9):666-682. [16] Fuentes B,Ntaios G,Putaala J,et al.European Stroke Organisation(ESO) guidelines on glycaemia management in acute stroke[J]. Eur Stroke J,2018,3(1):5-21. [17] Wein T,Lindsay MP,Côté R,et al.Canadian stroke best pra-ctice recommendations:secondary prevention of stroke,sixth edition practice guidelines,update 2017[J]. Int J Stroke,2018, 13(4):420-443. [18] Kleindorfer DO,Towfighi A,Chaturvedi S,et al.2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack:a guideline from the American Heart Association/American Stroke Association[J]. Stroke,2021, 52(7):e364-e467. [19] Korytkowski MT,Muniyappa R,Antinori-Lent K,et al.Manage-ment of hyperglycemia in hospitalized adult patients in non-critical care settings:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab,2022,107(8):2101-2128. [20] Kramer AH,Roberts DJ,Zygun DA.Optimal glycemic control in neurocritical care patients:a systematic review and meta-analysis[J]. Crit Care,2012,16(5):R203. [21] Cerecedo-Lopez CD,Cantu-Aldana A,Patel NJ,et al.Insulin in the management of acute ischemic stroke:a systematic review and meta-analysis[J]. World Neurosurg,2020,136:e514-e534. [22] Moghissi ES,Korytkowski MT,DiNardo M,et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control[J]. Diabetes Care,2009,32(6):1119-1131. [23] 中国医师协会内分泌代谢科医师分会,中国住院患者血糖管理专家组. 中国住院患者血糖管理专家共识[J]. 中华内分泌代谢杂志,2017,33(1):1-10. Chinese Endocrinologist,Chinese Medical Doctor Association,Expert group of blood glucose management for Chinese inpatieents. Expert consensus on blood glucose management for Chinese inpatients[J]. Chin J Endocrinol Metab,2017,33(1):1-10. [24] Rinkel LA,Nguyen TTM,Guglielmi V,et al.High admission glucose is associated with poor outcome after endovascular treatment for ischemic stroke[J]. Stroke,2020,51(11):3215-3223. [25] Aziz S,Sheikh Ghadzi SM,Abidin NE,et al.Gender differences and risk factors of recurrent stroke in type 2 diabetic Malaysian population with history of stroke:the observation from Malaysian national neurology registry[J]. J Diabetes Res,2019,2019:1794267. |